301 related articles for article (PubMed ID: 35650371)
1. Significance of the Vitamin D Receptor on Crosstalk with Nuclear Receptors and Regulation of Enzymes and Transporters.
Noh K; Chow ECY; Quach HP; Groothuis GMM; Tirona RG; Pang KS
AAPS J; 2022 Jun; 24(4):71. PubMed ID: 35650371
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on transporters and enzymes in fxr(+/+) and fxr(-/-) mice.
Chow EC; Durk MR; Maeng HJ; Pang KS
Biopharm Drug Dispos; 2013 Oct; 34(7):402-16. PubMed ID: 23897575
[TBL] [Abstract][Full Text] [Related]
3. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D and type II sodium-dependent phosphate cotransporters.
Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
[TBL] [Abstract][Full Text] [Related]
5. Highlighting Vitamin D Receptor-Targeted Activities of 1
Yang QJ; Bukuroshi P; Quach HP; Chow ECY; Pang KS
Drug Metab Dispos; 2018 Jan; 46(1):75-87. PubMed ID: 29084783
[TBL] [Abstract][Full Text] [Related]
6. 1Alpha,25-dihydroxyvitamin D3 up-regulates P-glycoprotein via the vitamin D receptor and not farnesoid X receptor in both fxr(-/-) and fxr(+/+) mice and increased renal and brain efflux of digoxin in mice in vivo.
Chow EC; Durk MR; Cummins CL; Pang KS
J Pharmacol Exp Ther; 2011 Jun; 337(3):846-59. PubMed ID: 21421739
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.
Guo YX; He LY; Zhang M; Wang F; Liu F; Peng WX
Neuroscience; 2016 May; 322():28-38. PubMed ID: 26820600
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of doxercalciferol (1α-hydroxyvitamin D₂) versus calcitriol (1α,25-dihydroxyvitamin D₃) on the expression of transporters and enzymes in the rat in vivo.
Chow EC; Sondervan M; Jin C; Groothuis GM; Pang KS
J Pharm Sci; 2011 Apr; 100(4):1594-604. PubMed ID: 20967888
[TBL] [Abstract][Full Text] [Related]
10. Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha,25-dihydroxyvitamin D3 via the vitamin D receptor.
Chen X; Chen F; Liu S; Glaeser H; Dawson PA; Hofmann AF; Kim RB; Shneider BL; Pang KS
Mol Pharmacol; 2006 Jun; 69(6):1913-23. PubMed ID: 16481392
[TBL] [Abstract][Full Text] [Related]
11. Expression and regulation of the bile acid transporter, OSTalpha-OSTbeta in rat and human intestine and liver.
Khan AA; Chow EC; Porte RJ; Pang KS; Groothuis GM
Biopharm Drug Dispos; 2009 Jul; 30(5):241-58. PubMed ID: 19562681
[TBL] [Abstract][Full Text] [Related]
12. Gene Expression Profiling of 1α,25(OH)
Pavek P; Dusek J; Smutny T; Lochman L; Kucera R; Skoda J; Smutna L; Kamaraj R; Soucek P; Vrzal R; Dvorak Z
Mol Nutr Food Res; 2022 May; 66(9):e2200070. PubMed ID: 35184385
[TBL] [Abstract][Full Text] [Related]
13. Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.
Wang H; LeCluyse EL
Clin Pharmacokinet; 2003; 42(15):1331-57. PubMed ID: 14674787
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.
Thummel KE; Brimer C; Yasuda K; Thottassery J; Senn T; Lin Y; Ishizuka H; Kharasch E; Schuetz J; Schuetz E
Mol Pharmacol; 2001 Dec; 60(6):1399-406. PubMed ID: 11723248
[TBL] [Abstract][Full Text] [Related]
15. 1alpha,25-Dihydroxyvitamin D(3) triggered vitamin D receptor and farnesoid X receptor-like effects in rat intestine and liver in vivo.
Chow EC; Maeng HJ; Liu S; Khan AA; Groothuis GM; Pang KS
Biopharm Drug Dispos; 2009 Nov; 30(8):457-75. PubMed ID: 19753549
[TBL] [Abstract][Full Text] [Related]
16. Alterations in gene expression in vitamin D-deficiency: Down-regulation of liver Cyp7a1 and renal Oat3 in mice.
Quach HP; Noh K; Hoi SY; Bruinsma A; Groothuis GMM; Li AP; Chow ECY; Pang KS
Biopharm Drug Dispos; 2018 Feb; 39(2):99-115. PubMed ID: 29243851
[TBL] [Abstract][Full Text] [Related]
17. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
18. 3D structures and ligand specificities of nuclear xenobiotic receptors CAR, PXR and VDR.
Wu B; Li S; Dong D
Drug Discov Today; 2013 Jun; 18(11-12):574-81. PubMed ID: 23299080
[TBL] [Abstract][Full Text] [Related]
19. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
Xu C; Li CY; Kong AN
Arch Pharm Res; 2005 Mar; 28(3):249-68. PubMed ID: 15832810
[TBL] [Abstract][Full Text] [Related]
20. Effects of 1alpha,25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney in vivo.
Chow EC; Sun H; Khan AA; Groothuis GM; Pang KS
Biopharm Drug Dispos; 2010 Jan; 31(1):91-108. PubMed ID: 20013813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]